Filing Details

Accession Number:
0001179110-19-013163
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-27 16:59:04
Reporting Period:
2019-12-24
Accepted Time:
2019-12-27 16:59:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1716468 M. Anthony Manning C/O Momenta Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-24 28,437 $12.58 33,880 No 4 M Direct
Common Stock Acquisiton 2019-12-24 16,258 $13.02 50,138 No 4 M Direct
Common Stock Acquisiton 2019-12-24 6,750 $10.83 56,888 No 4 M Direct
Common Stock Disposition 2019-12-24 51,445 $20.00 5,443 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option(Right to Buy) Disposition 2019-12-24 12,451 $0.00 12,451 $12.58
Common Stock Stock Option(Right to Buy) Disposition 2019-12-24 14,804 $0.00 14,804 $13.02
Common Stock Stock Option (Right to Buy) Disposition 2019-12-24 1,454 $0.00 1,454 $13.02
Common Stock Stock Option(Right to Buy) Disposition 2019-12-24 15,986 $0.00 15,986 $12.58
Common Stock Stock Option (Right to Buy) Disposition 2019-12-24 6,750 $0.00 6,750 $10.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-11-19 2023-02-19 No 4 M Direct
73 2018-02-18 2025-02-18 No 4 M Direct
5,841 2018-02-18 2025-02-18 No 4 M Direct
0 2017-02-19 2025-05-20 No 4 M Direct
1,499 2018-05-09 2026-02-09 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person December 14, 2018.